[1] |
Massad L, Einstein M, Huh W, et al. 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors [J]. J Low Genit Tract Dis, 2013, 17(5 Suppl 1): S1-27.
|
[2] |
Colposcopy and Programme Management. Guidelines for the NHS Cervical Screening Programme [EB/OL]. 2004-04].
URL
|
[3] |
Ghaem-Maghami S, Sagi S, Majeed G, et al. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis [J]. Lancet Oncol, 2007, 8(11): 985-993.
|
[4] |
Lu C, Liu F, Tseng J, et al. Predictive factors for residual disease in subsequent hysterectomy following conization for CIN Ⅲ [J]. Gynecol Oncol, 2000, 79: 284-288.
|
[5] |
Ayhan A, Boynukalin F, Guven S, et al. Repeat LEEP conization in patients with cervical intraepithelial neoplasia grade 3 and positive ectocervical margins [J]. Int J Gynaecol Obstet, 2009, 105(1): 14-17.
|
[6] |
Kyehyun N, Jeongja K, Kim J. Human papillomavirus type 16 causes larger colposcopic lesions than other HPV types in patients with grade 3 cervical intraepithelial neoplasia. American Society for Colposcopy and Cervical Pathology [J]. J Low Genit Tract Dis, 2013, 17(1): 1-5.
|
[7] |
Diaz E, Aoyama C, Baquing M, et al. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins [J]. Gynecol Oncol, 2014, 132(1): 76-80.
|
[8] |
Kim H, Kim K, Mok J, et al. Pathologic risk factors for predicting residual disease in subsequent hysterectomy following LEEP conization [J]. Gynecol Oncol, 2007, 105(2): 434-438.
|
[9] |
Tasci T, Turan T, Ureyen I, et al. Is there any predictor for residual disease after cervical conization with positive surgical margins for HSIL or microinvasive cervical cancer? [J]. J Low Genit Tract Dis, 2015, 19(2): 115-118.
|
[10] |
常艳红, 田林. 宫颈癌及癌前病变的病例对照研究[J]. 中国卫生统计, 2016, 33(1): 120-122.
|
[11] |
Lu H, Wan X, Lv W, et al. Factors associated with positive margins in patients with cervical intraepithelial neoplasia grade 3 and postconization management [J]. Int J Gynaecol Obstet, 2009, 107(2): 107-110.
|
[12] |
Soutter W, Sasieni P, Panoskaltsis T. Long-term risk of invasive cervical carcinoma after treatment of squamous cervical intraepithelial neoplasia [J]. Int J Cancer, 2006, 118(8): 204820-204855.
|
[13] |
Kalliala I, Anttila A, Pukkala E, et al. Risk of cervical and other carcinomas after treatment of cervical intraepithelial neoplasia: retrospective cohort study [J]. BMJ, 2005, 331(7526): 1183-1185.
|
[14] |
Benedet J, Bender H, Jones H, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic carcinomas. FIGO Committee on Gynecologic Oncology [J]. Int J Gynecol Obstet, 2000, 70(2): 209-262.
|